ScholarLens Back to search
2022•Kidney International ReportsOpen access

POS-794 Conversion to sirolimus in kidney transplant patients: the main indications

Noura Magdy Thabet, A. Azzabi, Haroun Hafsa, W. Sahtout, M. Hamouda, S. Yaïch, L. Ben Fatma, M. Bacha, Habib Skhiri, M. Ben Hmida, M.K. Zouaghi, T. Ben Abdallah, Y. Guedri, S. Mrabet, A. Achour

Open full text 0 citations

Abstract

The mTOR inhibitors (Sirolimus) has been used in kidney transplantation for very specific indications, essentially in case of neoplastic complications after transplantation secondary to calcineurin inhibitors.Then, the indications have been extended.To describe the different indications of sirolimus conversion in renal transplant patients in Tunisia, we carried out a multicenter study.

Open-access reader

About this research paper

What this paper is about

The mTOR inhibitors (Sirolimus) has been used in kidney transplantation for very specific indications, essentially in case of neoplastic complications after transplantation secondary to calcineurin inhibitors.Then, the indications have been extended.To describe the different indications of sirolimus conversion in renal transplant patients in Tunisia, we carried out a multicenter study.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The mTOR inhibitors (Sirolimus) has been used in kidney transplantation for very specific indications, essentially in case of neoplastic complications after transplantation secondary to calcineurin inhibitors.Then, the indications have been extended.To describe the different indications of sirolimus conversion in renal transplant patients in Tunisia, we carried out a multicenter study.

Key concepts: Sirolimus, Medicine, Calcineurin, Discovery and development of mTOR inhibitors, Kidney transplantation, Transplantation, Urology, Kidney transplant

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
POS-794 Conversion to sirolimus in kidney transplant patients: the main indications — Research Paper | ScholarLens